Clinical Trial Update: Safety and Preliminary Efficacy Study of NeoFuse in Subjects Undergoing Multi-Level Anterior Cervical Discectomy [Phase 2]

View source ↗

Summary

Phase 2 safety and preliminary efficacy study of NeoFuse in subjects undergoing multi-level anterior cervical discectomy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Degenerative Disc Disease
• Degenerative Spondylolisthesis
• Spinal Stenosis

Drugs mentioned

• NeoFuse

Snippet

Sponsor: Mesoblast, Ltd. | Conditions: Cervical Degenerative Disc Disease, Degenerative Spondylolisthesis | Phase 2 | Status: COMPLETED